SERIOUS INFECTION RISK IN PEDIATRIC PATIENTS WITH LOW IMMUNOGLOBULIN LEVELS FOLLOWING RITUXIMAB TREATMENT FOR GRANULOMATOSIS WITH POLYANGIITIS (GPA) OR MICROSCOPIC POLYANGIITIS (MPA)

被引：0

作者：

Melega, S. ^{[1
]}

Brogan, P. ^{[2
,3
]}

Cleary, G. ^{[4
]}

Hersh, A. ^{[5
]}

Kasapcopur, O. ^{[6
]}

Rangaraj, S. ^{[7
]}

Yeung, R. ^{[8
,9
]}

Zeft, A. ^{[10
]}

Cooper, J. ^{[11
]}

Pordeli, P. ^{[12
]}

Kirchner, P. ^{[1
]}

Lehane, P. ^{[13
]}

机构：

[1] F Hoffmann La Roche Ltd, Basel, Switzerland

[2] UCL Inst Child Hlth, London, England

[3] Great Ormond St Hosp Sick Children, London, England

[4] Alder Hey Childrens Hosp, Liverpool, Merseyside, England

[5] Univ Utah, Primary Childrens Hosp, Salt Lake City, UT USA

[6] Istanbul Univ Cerrahpasa, Cerrahpasa Med Sch, Cerrahpasa, Turkey

[7] Nottingham Univ Hosp, Nottingham, England

[8] Hosp Sick Children, Toronto, ON, Canada

[9] Univ Toronto, Toronto, ON, Canada

[10] Cleveland Clin, Cleveland, OH 44106 USA

[11] Childrens Hosp Colorado, Aurora, CO USA

[12] Roche Prod Ltd, Mississauga, ON, Canada

[13] Roche Prod Ltd, Welwyn Garden City, Herts, England

来源：

关键词：

D O I：

10.1136/annrheumdis-2020-eular.750

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

SAT0503

引用

页码：1203 / 1204

页数：2